CIMVA Product Pipeline

The CIMVA Universal software platform is the foundation for a number of future CIMVA clinical applications  targeting specified clinical indications with unmet needs.   Our two initial clinical products now in studies in hospitals across North America are focused on determining:

  1. Readiness to remove a patient in the ICU from mechanical ventilation; and
  2. Risk of rapid deterioration from infection in patients in the emergency department.

Other high need critical care areas are being assessed using CIMVA technology, including among other, when to decrease the level of sedation in ICU patients.  TMS is actively pursuing a partnering program with clinician researchers and companies interesting in the application of complexity science to critical care patient care in order to expand our pipeline of clinical products (view more information on the Partnering page).